Healthcare
FDA Adds GLP-1 Eye-Risk Warning After Reviewing 126 Clinical Trials
The US Food and Drug Administration (FDA) has ordered manufacturers of glucagon-like peptide-1 (GLP-1) medicines to update their product labelling...












